MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab ...

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

OmniAb, Inc. (NASDAQ: OABI) announces the launch of its new OmniUltra™ platform, the industry’s first and only transgenic ...

Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...

Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.

Adults with shrimp allergy report reduced quality of life and a desire for therapies that would allow them to safely eat a full serving of shrimp.

Discusses Launch and Scientific Overview of OmniUltra Technology Platform December 15, 2025 5:00 PM ESTCompany ...

REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...